Left ventricular dysfunction is a specific problem where the left side of the heart isn't pumping blood well. This often leads to heart failure.
Every report comes from a Lived member, sent anonymously.
Have you tried Entresto (Sacubitril / Valsartan) for Left Ventricular Dysfunction?
Left ventricular dysfunction means the left ventricle, the heart's main pumping chamber, is not working as well as it should. This chamber sends oxygen-rich blood out to the rest of the body, so when it falters, the whole circulation is affected. The problem takes two main forms. In systolic dysfunction, the muscle squeezes weakly and pumps out less blood with each beat. In diastolic dysfunction, the muscle squeezes normally but has become thick or stiff, so it does not relax and fill properly between beats. Both can raise pressure in the lungs and lead to the breathlessness, tiredness and fluid swelling of heart failure. Left ventricular dysfunction is a description of how the heart is working rather than a single disease, and it often causes no symptoms at first. When the heart is measurably abnormal but symptoms have not appeared, doctors call it pre-heart failure (stage B). Finding it at that point matters, because treatment can lower the chance that it progresses to heart failure.
Most left ventricular dysfunction is the result of something else that has strained or damaged the heart muscle. Coronary artery disease and heart attacks are leading causes: when part of the muscle loses its blood supply, that area can scar and stop contracting. Long-standing high blood pressure makes the heart work against extra resistance, which thickens and stiffens the wall over years and can eventually weaken it. Other causes include heart valve disease, inherited or acquired cardiomyopathies (diseases of the heart muscle itself), persistently fast or irregular heart rhythms, viral or other infections of the heart, heavy alcohol use, and some chemotherapy and radiation treatments for cancer. Thyroid disease and severe anemia can also play a part, and they are worth identifying because they can be treated. Diabetes, obesity, chronic kidney disease and older age make dysfunction more likely, and diastolic dysfunction in particular is common in older adults with high blood pressure or diabetes. Close relatives of someone with an inherited cardiomyopathy have a higher risk even if they feel well. These are risk factors, not certainties, and controlling the treatable ones can protect the heart.
The main test is an echocardiogram, an ultrasound of the heart. It shows the size and thickness of the left ventricle, how well each part of the wall moves, how the valves work and, using Doppler measurements of blood flow, how well the chamber relaxes and fills. Dysfunction is often first found on an echocardiogram done for another reason, such as after a heart attack, before or during cancer treatment, or to look into a heart murmur. The key number for pumping is the ejection fraction: the percentage of blood in the left ventricle that is pushed out with each beat. A healthy heart does not empty completely, so an ejection fraction of 50% or higher is in the preserved range. An ejection fraction of 41% to 49% is mildly reduced, and 40% or lower is reduced. The measurement can vary somewhat between tests and readers, so a single borderline result is usually interpreted alongside the rest of the picture. Diastolic dysfunction is judged from several filling measurements rather than one number, and it can be present even when the ejection fraction is normal. A blood test for B-type natriuretic peptide (BNP), a hormone released when heart muscle is under strain, can support the diagnosis, though levels are also affected by other factors; obesity, for example, tends to lower them. Doctors usually add an electrocardiogram (ECG) to look at heart rhythm and signs of past damage, blood tests to look for thyroid, kidney or blood count problems, and tests for blocked coronary arteries when that is a possible cause. Cardiac magnetic resonance imaging (MRI) gives the most precise measure of ejection fraction and can show scarring or inflammation in the muscle.
Treatment depends on whether the problem is weak pumping or stiff filling, whether symptoms are present, and what caused it. Treating the cause comes first where possible: controlling blood pressure, opening or bypassing blocked arteries, repairing a faulty valve, controlling a fast heart rhythm or stopping alcohol can each relieve strain on the ventricle and sometimes allow it to recover. When the ejection fraction is reduced, medicines are often started even if a person feels well. In a large trial of people with an ejection fraction of 35% or lower and no symptoms, the angiotensin-converting enzyme (ACE) inhibitor enalapril lowered the chance of developing heart failure and of being hospitalized for it, although it did not clearly reduce deaths. ACE inhibitors and the related angiotensin receptor blockers (ARBs) relax blood vessels and ease the work of the heart. Beta blockers, which slow the heart rate and shield it from stress hormones, are also widely used, especially after a heart attack. Once heart failure symptoms develop with a reduced ejection fraction, guidelines agree on four medicine families taken together, because each adds protection: a drug acting on the renin-angiotensin system (often sacubitril/valsartan, sold as Entresto, or an ACE inhibitor or ARB), a beta blocker such as carvedilol, a mineralocorticoid receptor antagonist such as spironolactone, and a sodium-glucose cotransporter 2 (SGLT2) inhibitor such as dapagliflozin (Farxiga), originally a diabetes medicine that also lowers heart failure hospitalization and death. Diuretics (water pills) relieve fluid buildup but are used for symptoms rather than long-term protection. These medicines are usually started at low doses and increased gradually, with blood tests to check kidney function and potassium, and some can cause dizziness from low blood pressure. ACE inhibitors, ARBs and sacubitril/valsartan can harm a developing baby, so pregnancy plans and contraception are part of the conversation. Some people whose ejection fraction stays low face a higher risk of dangerous heart rhythms. An implantable cardioverter defibrillator (ICD), a small device placed under the skin that shocks the heart back into rhythm, improves survival in selected people, such as those with an ejection fraction of 30% or lower after a heart attack or 35% or lower with heart failure symptoms despite several months of medicine. Because the ejection fraction often improves with treatment, this decision is usually made after medicines have had time to work. A biventricular pacemaker (cardiac resynchronization therapy) can help certain people whose ECG shows the two sides of the heart contracting out of step. For diastolic dysfunction without symptoms, the focus is on controlling blood pressure, diabetes, weight and heart rhythm. If heart failure symptoms develop with a preserved ejection fraction, diuretics ease congestion and SGLT2 inhibitors such as dapagliflozin can reduce hospital visits.
The course varies widely. Some people, particularly when a reversible cause is found and treated, see their ejection fraction improve substantially, and some return to the normal range. Others stay stable for years without symptoms, while some go on to develop heart failure. Improvement on treatment is encouraging, but it does not mean the heart has fully healed: in people with dilated cardiomyopathy whose ejection fraction improved, a substantial share saw it fall again when treatment was stopped. Any change to heart medicines is best made with the cardiology team rather than alone. Follow-up usually includes repeat echocardiograms to track the ejection fraction, blood tests while medicines are adjusted, and regular visits, which are typically every few months once heart failure is present. Many people need several visits to reach the right medicine doses. Most people can stay active, and regular physical activity is encouraged within a plan agreed with the care team; cardiac rehabilitation can help build confidence and fitness. Limiting salt, not smoking, limiting alcohol and keeping blood pressure and diabetes controlled all reduce strain on the heart. Common over-the-counter pain relievers such as ibuprofen (Advil, Motrin) and naproxen (Aleve) can make heart failure worse, so it is worth asking before taking any new medicine or supplement. People who have had heart failure symptoms are often asked to weigh themselves each morning, because a quick rise in weight is an early sign of fluid buildup. Living with a heart condition can bring worry or low mood, and these are worth raising, since support and treatment help.
Ask about an evaluation if you have new breathlessness during activity, unusual tiredness or ankle swelling, or if you have a reason to be checked before symptoms appear, such as a close relative with cardiomyopathy or cancer treatment known to affect the heart. If you have been diagnosed, contact your care team promptly if your weight rises by more than 2 to 3 pounds in a day or 5 pounds in a week, swelling in your legs or belly increases, you become short of breath at rest or when lying flat, you wake at night breathless, or you develop a cough that will not go away. Also call if your pulse becomes very slow, very fast or irregular, or if a medicine leaves you dizzy or lightheaded. Call 911 if you have severe or sudden trouble breathing, such as struggling for breath while resting or coughing up bloody froth, which can mean fluid has flooded the lungs. Also call 911 if you faint, have severe chest pain, or have a fast, irregular heartbeat along with other symptoms such as lightheadedness.
Last reviewed • Oct 2026
Educational content, not medical advice.
I'm getting mixed opinions from my cardiologist and primary care doctor about whether or not this is a concern. Cardio thinks it's not a big deal, primary care says it could lead to heart failure if we ignore it. Anyone else have experience with Stage 2?